rationale recurrent pulmonary exacerbations associated progressive lung disease cystic fibrosis cf current definitions exacerbation precisely defined include symptoms declining lung function changing radiologic appearance early diagnosis exacerbations rapid noninvasive means expedite therapeutic intervention minimizing lung damage objectives identify biomarkers lung exacerbation monitoring cf lung disease progression methods sputum collected adults cf exacerbation requiring hospitalization fev1 NUMBER subset adults hospital discharge children stable cf preserved lung function fev1 NUMBER control subjects fev1 NUMBER sputum arrayed electrophoresis differentially expressed proteins identified proteomic analysis measurements main results sputum profiles adults cf exacerbation characterized extensive proteolytic degradation influx proteins adults cf approaching healthy protein profile hospitalization children cf showed profiles biomarker expression resembling adults exacerbation levels differentially expressed myeloperoxidase cleaved igg degradation total protein concentration correlation fev1 statistically significant statistical correlation analyses indicated changes myeloperoxidase expression igg degradation strongest predictors fev1 conclusions identified extensive protein degradation differentially expressed proteins biomarkers inflammation relating pulmonary exacerbations prediction exacerbation onset precise evaluation extent resolution treatment achieved including biomarkers standard assessment point care saline induced dimensional inflammation related alpha1 antitrypsin interleukin NUMBER new worsening